119 related articles for article (PubMed ID: 17538565)
1. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapeutics for rheumatoid arthritis.
Bingham CO
Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets for rheumatoid arthritis: Progress and promises.
Alghasham A; Rasheed Z
Autoimmunity; 2014 Mar; 47(2):77-94. PubMed ID: 24437572
[TBL] [Abstract][Full Text] [Related]
4. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
5. Emerging cytokine targets in rheumatoid arthritis.
Asquith DL; McInnes IB
Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
[TBL] [Abstract][Full Text] [Related]
6. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
7. Regulators of cytokine signalling in rheumatoid arthritis.
Rahman A
Rheumatology (Oxford); 2007 Dec; 46(12):1745-6. PubMed ID: 17986480
[No Abstract] [Full Text] [Related]
8. Prospective new biological therapies for rheumatoid arthritis.
Senolt L; Vencovský J; Pavelka K; Ospelt C; Gay S
Autoimmun Rev; 2009 Dec; 9(2):102-7. PubMed ID: 19328245
[TBL] [Abstract][Full Text] [Related]
9. Kinase inhibitors: a new approach to rheumatoid arthritis treatment.
Cohen S; Fleischmann R
Curr Opin Rheumatol; 2010 May; 22(3):330-5. PubMed ID: 20164774
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage.
Beyer C; Schett G
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):489-96. PubMed ID: 20732647
[TBL] [Abstract][Full Text] [Related]
11. MAPKs and their relevance to arthritis and inflammation.
Thalhamer T; McGrath MA; Harnett MM
Rheumatology (Oxford); 2008 Apr; 47(4):409-14. PubMed ID: 18187523
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.
Herman S; Krönke G; Schett G
Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489
[TBL] [Abstract][Full Text] [Related]
14. At the horizon of innovative therapy in rheumatology: new biologic agents.
Finckh A; Gabay C
Curr Opin Rheumatol; 2008 May; 20(3):269-75. PubMed ID: 18388517
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis.
Kumar S; Blake SM; Emery JG
Curr Opin Pharmacol; 2001 Jun; 1(3):307-13. PubMed ID: 11712756
[TBL] [Abstract][Full Text] [Related]
16. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
Renato GM
Ann N Y Acad Sci; 2009 Sep; 1173():729-35. PubMed ID: 19758222
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
18. Molecular therapeutic targets in rheumatoid arthritis.
Sacre SM; Andreakos E; Taylor P; Feldmann M; Foxwell BM
Expert Rev Mol Med; 2005 Aug; 7(16):1-20. PubMed ID: 16117838
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.
Müller-Ladner U; Pap T; Gay RE; Neidhart M; Gay S
Nat Clin Pract Rheumatol; 2005 Dec; 1(2):102-10. PubMed ID: 16932639
[TBL] [Abstract][Full Text] [Related]
20. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.
La DT; Collins CE; Yang HT; Migone TS; Stohl W
Ann Rheum Dis; 2008 Aug; 67(8):1132-8. PubMed ID: 17967830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
